Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNAPTICS Inc Director's Dealing 2014

Aug 6, 2014

31479_dirs_2014-08-06_6683717b-cc3e-437c-8f6e-b3ee4c1e61e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS INC (SYNA)
CIK: 0000817720
Period of Report: 2014-08-04

Reporting Person: BAYLESS KATHLEEN A (SVP, CFO, & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-04 Common Stock M 10000 $19.40 Acquired 23281 Direct
2014-08-04 Common Stock M 10000 $27.99 Acquired 33281 Direct
2014-08-04 Common Stock S 19500 $77.0383 Disposed 13781 Direct
2014-08-04 Common Stock S 500 $77.966 Disposed 13281 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-04 Employee Stock Option (Right to Buy) $19.40 M 10000 Disposed 2019-03-02 Common Stock (10000) Direct
2014-08-04 Employee Stock Option (Right to Buy) $27.99 M 10000 Disposed 2018-01-24 Common Stock (10000) Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Sales Plan dated February 24, 2014.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.58 to $77.51,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.61 to $78.16,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F4: 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the March 2, 2009 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month thereafter until fully vested on March 2, 2013.

F5: 1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 24th day of each month following the date of grant until fully vested on January 24, 2015.

F6: The expiration date was previously erroneously reported as 1/24/2021.